Evaluation and follow-up of antibody formation after CoronaVac vaccine
Yazarlar (6)
Öğr. Gör. Büşra Çalışır Kastamonu Training And Research Hospital, Türkiye
Nilay Çöplü
Kastamonu Üniversitesi, Türkiye
Kastamonu Üniversitesi, Türkiye
Dr. Öğr. Üyesi Melike Yaşar Duman Kastamonu Training And Research Hospital, Türkiye
Çetin Kılınç
Kastamonu Training And Research Hospital, Türkiye
Kastamonu Training And Research Hospital, Türkiye
Dr. Öğr. Üyesi Rıdvan ÖZBEK Kastamonu Training And Research Hospital, Türkiye
Prof. Dr. Zafer ERGÜL Kastamonu Üniversitesi, Türkiye
| Makale Türü |
Özgün Makale
(SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
|
||
| Dergi Adı | Revista Da Associacao Medica Brasileira (Q4) | ||
| Dergi ISSN | 0104-4230 Wos Dergi Scopus Dergi | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 01-2022 |
| Cilt / Sayı / Sayfa | 68 / 12 / 1769–1773 | DOI | 10.1590/1806-9282.20221074 |
| Makale Linki | https://www.scielo.br/j/ramb/a/yVLFgK7BqmSBQnpY6xwQ5vr/ | ||
| UAK Araştırma Alanları |
Tıbbi Mikrobiyoloji
|
||
| Özet |
| OBJECTIVE The aim of this study was to monitor the time-dependent change by evaluating the antibody levels at the 4th, 7th, 10th, 13th, and 16th weeks after the second dose of the CoronaVac vaccine. METHODS The study group (n=65) were between 21 and 60 years old and received two doses of the CoronaVac vaccine. Blood samples were collected after 4th, 7th, 10th, 13th, and 16th weeks of the second dose of the vaccine administration. There was a coronavirus disease 2019 recovered group (n=29) who were SARS-CoV-2 real-time PCR test result positive before the vaccination period, and no coronavirus disease 2019 history group (n=36). Age, BMI, gender, smoking, comorbidity, coronavirus disease 2019 contact history, and working in the coronavirus disease 2019 service history of the individuals were recorded. RESULTS No statistically significant difference was found in the descriptive findings of the individuals according to coronavirus disease 2019 recovered group and no coronavirus disease 2019 history group. It was observed that antibody levels in the coronavirus disease 2019 recovered group were found to be higher for each period of serum collection compared to the no coronavirus disease 2019 history group, which were statistically significant. The distribution curves of the antibody levels according to the timing of blood collection in coronavirus disease 2019 recovered group, no coronavirus disease 2019 history group, and total subjects were extrapolated, and it was observed that the estimated time for the antibodies to reach the threshold value of the test was 214 … |
| Anahtar Kelimeler |
| COVID-19. Vaccines | humoral | ınactivated. Immunity |
BM Sürdürülebilir Kalkınma Amaçları
| Atıf Sayıları | |
| Scopus | 2 |
| Google Scholar | 2 |